Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer-Reference-Cited by-同舟云学术

Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer

Published:2023-10-16 Issue:19 Volume:149 Page:17651-17661
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Moreira Rodrigo Santiago,da Silva Marillya Morais,de Melo Vasconcelos César Freire,da Silva Thiago Douberin,Cordeiro Gabriel Guerra,Mattos-Jr Luiz Alberto Reis,da Rocha Pitta Maira Galdino,de Melo Rêgo Moacyr Jesus Barreto,Pereira Michelly Cristiny

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05437-z.pdf

Reference70 articles.

1. Aguirre-Ducler A et al (2022) Tumor cell SYK expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling. J Immunother Cancer 10(7):e005113

2. Alfranca YL, Garcia MEO, Rueda AG, Ballesteros PÁ, Rodríguez DR, Velasco MT (2022) Blood biomarkers of response to immune checkpoint inhibitors in non-small cell lung cancer. J Clin Med 11(11):3245

3. Altorki NK et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 19(1):9–31

4. American Cancer Society (2023) Facts and figures 2023. American Cancer Society, Atlanta

5. Angata T (2020) Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases. J Biomed Sci 27(1):1–7

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycosylation: mechanisms, biological functions and clinical implications;Signal Transduction and Targeted Therapy;2024-08-05

2. A Novel Electrochemiluminescence (ECL) Immunoassay for the Quantitation of Monoclonal Antibody (mAb) PYX-106 in Human Serum;Current Analytical Chemistry;2024-07